The funding was led by Founders Fund. This comes a few months after Neuralink received FDA approval for human trials of its brain implant.
Neuralink, a company from Elon Musk, seeks to address spinal cord injuries through the brain implant and has been tested in animals. However, some experts are warning the company in light of safety concerns.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.